The pelvic floor exam is an integral part of the evaluation of pelvic floor disorders, including palpation to assess for hypertonicity, banding and pain. Different levels of pressure may result in different pain thresholds and variability exists amongst examiners. The aim of this study was to determine the reproducibility of the pelvic floor exam using a quantitative approach.
INTRODUCTION AND OBJECTIVES:
The pelvic floor exam is an integral part of the evaluation of pelvic floor disorders, including palpation to assess for hypertonicity, banding and pain. Different levels of pressure may result in different pain thresholds and variability exists amongst examiners. The aim of this study was to determine the reproducibility of the pelvic floor exam using a quantitative approach.
METHODS: Study participants included FPMRS fellows, FPMRS faculty, urology residents, nurse practitioners (NP) and pelvic floor physical therapists (PT). A gram scale and foam vagina model were used to record pressure measurements. Standardized "mild" and "moderate" pressure ranges were first established a priori (280-424 gm for mild; 442-906 gm for moderate). Participants were blinded and asked to apply mild and moderate pressure, and these values were recorded. Then they were unblinded and in-serviced on the expected range for mild and moderate. They were immediately re-blinded and asked to reproduce mild and moderate pressure. The same thirdparty member recorded three mild and three moderate pressure values from each participant. ANOVA repeated measures were used to test for the significance in the difference between the measurements with and without teaching. Significance level was set to 0.025 for each comparison within a given group of providers. RESULTS: For mild pressure both residents and NP/PT were outside of the range without teaching, and applied greater pressure than the desired range, but with teaching fell within the established range. (see table) . For moderate pressure, both residents and NP/PT applied significantly greater pressure without teaching compared to with teaching, but were always within an acceptable range (see table) . Faculty/fellows applied appropriate mild and moderate pressure both without and with teaching. Unlike the resident and NP/PT groups, faculty/fellows tended to apply lighter pressure without teaching.
CONCLUSIONS: An accurate exam is critical to diagnosing pelvic floor disorders and there is a need for a more standardized and objective approach. A quantitative method is both teachable and reproducible. This holds true for practitioners that do not routinely perform pelvic floor exams.
Source of Funding: none

PD65-03 TO STAGE OR NOT TO STAGE? -A COST MINIMIZATION ANALYSIS OF SACRAL NEUROMODULATION PLACEMENT STRATEGIES
Andrew Sun*, Catherine Harris, Craig Comiter, Christopher Elliott, Stanford, CA INTRODUCTION AND OBJECTIVES: Sacral neuromodulation (SNM) is a standard therapy for refractory overactive bladder (OAB). Traditionally, SNM placement involves placement of an S3 lead with 1-3 weeks of testing before considering a permanent implant. Given the potential risk of bacterial contamination during testing and high success rates published by some experts, we compared the costs of traditional 2-stage against single-stage SNM placement for OAB.
METHODS: We performed a cost minimization analysis using published data on 2-stage SNM success rates, SNM infection rates, and direct reimbursements from Medicare for 2017 (Figure 1) . We compared the costs associated with a 2-stage versus single-stage approach. We performed sensitivity analyses of the primary variables to assess where threshold values occurred and used separate models for freestanding ambulatory surgery centers (ASC) and outpatient hospital departments (OHD).
RESULTS: Based on published literature, our base case assumed a 69% SNM success rate, a 5% 2-stage approach infection rate, a 1.7% single-stage approach infection rate, and removal of 50% of non-working single-stage SNMs. In both ASC ($17,613 vs $18,194) and OHD ($19,832 vs $21,181) settings, single-stage SNM placement was less costly than 2-stage placement. The minimum SNM success rates to achieve savings with a single-stage approach occur at 65.4% and 61.3% for ASC and OHD, respectively (Figure 2) . CONCLUSIONS: Using Medicare reimbursement, single-stage SNM placement is likely to be less costly than 2-stage placement for most practitioners. The savings are tied to SNM success rates and reimbursement rates, with the success in centers of excellence (w90%) saving up to $5014 per case.
